Remedium Lifecare Reports Significant Financial Decline, Adjusts Evaluation Amid Challenges

Remedium Lifecare, a microcap company in the Trading & Distributors industry, has reported its financial results for the quarter ending June 2025. The results, declared on August 4, 2025, indicate a significant decline in various financial metrics, leading to an adjustment in evaluation.
The company's net sales for the quarter stood at Rs 18.37 crore, reflecting a substantial year-on-year decline. This marks the lowest sales figure recorded in the last five quarters, suggesting a challenging market environment. Additionally, the profit before tax, less other income, registered at Rs -3.85 crore, indicating a notable shift in financial health compared to the previous year. The profit after tax also showed a negative trend, with a reported figure of Rs -0.37 crore.

Furthermore, the operating profit margin reached its lowest point in five quarters at -22.92%, highlighting a decline in operational efficiency. The debtors turnover ratio, at 0.38 times, is the lowest observed in the last ten half-yearly periods, indicating a slowdown in the company's ability to settle its debts.

Overall, these results have led to a revision in Remedium Lifecare's score, reflecting the current financial challenges faced by the company.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.